Skip to main content
. Author manuscript; available in PMC: 2020 Apr 4.
Published in final edited form as: Arch Pathol Lab Med. 2019 Aug 20;144(4):466–472. doi: 10.5858/arpa.2018-0526-OA

Figure 3.

Figure 3.

Kaplan-Meier curves comparing event-free survival (A) (P = .60) and overall survival (B) (P = .38) between acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in patients with Down syndrome.